Karim L, Bouxsein ML. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties. Bone. 2015, 07, 028. pII: S8756-3282.
Nicodemus KK, Folsom AR. Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001, 24: 1192-1197.
Inzerillo AM, Epstein S. Osteoporosis and diabetes mellitus. RevEndocr Metab Disord. 2004, 5: 261-268.
Leiding-Bruckner G., Ziegler R. Diabetes mellitus - a risk for osteoporosis? Exp Clin Endocrinol Diabetes. 2001, 109: S493-514.
Patsch JM, Burghardt AJ, Yap SP, Baum T, Schwartz AV, Joseph GB, Link TM. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. Journal of Bone and Mineral Research. 2013, 28(2): 313-324.
Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced crosslinks as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporosis International. 2006, 17(10): 1514-1523.
Vestergaard P, Rejnmark L & Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcified Tissue International. 2009, 84(1): 45-55.
Hough S, Pierroz D, Cooper C, Ferrari S. Mechanisms in endocrinology: Mechanisms and Evaluation of Bone Fragility in Type 1 Diabetes Mellitus. Eur J Endocrinol. 2015, 4(2): EJE-15-0820.
Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeo-stasis. Journal of Bone and Mineral Research. 2011, 26(4): 677-680.
Wei J, Ferron M, Clarke CJ, Hannun YA, Jiang H, Blaner WS, Karsenty G. Bone-specific insulin resistance disrupts whole-body glucose homeo-stasis via decreased osteocalcin activation. Journal of Clinical Investigation. 2014, 124(4): 1781-1793.
McNair P, Madsbad S, Christiansen C, Christensen MS, Faber OK, Binder C, Transbol I. Bone loss in diabetes: effects of metabolic state. Diabetologia. 1979, 17(5): 283-286.
Eknoyan G, Lewin A, Levin N. National Kidney Foundation. K/DOOI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American Journal of Kidney Diseases. 2003, 42 S1-S202.
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type
and type 2 diabetes - a meta-analysis. Osteoporosis International. 2007, 18(4): 427-444.
Khazai NB., Beck GR, and Umpierrez GE Diabetes and Fractures - An overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009, 16(6): 435-445.
Lee RH, Pieper CF, Colon-Emeric C. Functional Impairments Mediate Association Between Clinical Fracture Risk and Type 2 Diabetes Mellitus in Older Women. J Am Geriatr Soc. 2015, 63(8): 1546-1551.
Лесняк О.М., Никитинская О.А., Торопцова Н.В., Белая Ж.Е., Каронова Т.Л. и соавт. Профилактика, диагностика и лечение дефицита витамина D и кальция у взрослого населения России и пациентов с остеопорозом (по материалам клинических рекомендаций). Научно-практическая ревматология. 2015, 53(4): 403-408.
Mathen PG, Thabah MM, Zachariah B, Das AK. Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type
Diabetes. J Clin Diagn Res. 2015, 9(9): OC08-12.
Benvenuti S, Cellai I, Luciani P, Deledda C, Baglioni S, Giuliani C, et al. Rosiglitazone stimulates adipo-genesis and decreases osteoblastogenesis in human mesenchymal stem cells. Journal of Endocrinological Investigation. 2007, 30(9): 26-30.
Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005, 48(7): 1292-1299.
Hegazy SK, Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmen-opausal diabetic women. J Bone Miner Metab. 2015, 33(2): 207-212.
Ma P, Gu B, Xiong W, Tan B, Geng W, Li J, Liu H, Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose microenvironment. PLoS One. 2014, 9(11): e112243.
Ma P, Tan B, Liu H, Ma J, Gu B, Effect of glime-piride on the glucose uptake of rat mandibular osteoblasts in hyperglycemia. Hua Xi Kou Qiang Yi Xue Za Zhi. 2014, 32(2): 125-129.
Rajpathak SN, Fu C, Brodovicz KG, Engel SS, Lapane K, Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes. Drugs Aging. 2015, 32(4): 321-327.
Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ & Christiansen C. Role of gastrointestinal hormones in postprandial reduction of bone resorption. Journal of Bone and Mineral Research. 2003. 18(12): 2180-2189.
Бабенко А.Ю., Неймарк А.Е., Анисимова К.А., Гринева Е.Н. Эффекты бариатрических операций на уровень гормонов, регулирующих массу тела. В чем основа успеха? Ожирение и метаболизм, 2014. 4: 3-11.